Gilvocarcin V

Last updated
Gilvocarcin V
Gilvocarcin V.svg
Names
IUPAC name
4-[3,4-Dihydroxy-5-(1-hydroxyethyl)oxolan-2-yl]-8-ethenyl-1-hydroxy-10,12-dimethoxynaphtho[1,2-c]isochromen-6-one [1]
Other names
NSC348115, [1] Anandimycin A, [2] Toromycin B, [2] Antibiotic 1072B [2]
Identifiers
3D model (JSmol)
ChemSpider
PubChem CID
  • InChI=1S/C27H26O9/c1-5-12-8-15-19(17(9-12)33-3)14-10-18(34-4)21-16(29)7-6-13(20(21)25(14)36-27(15)32)26-23(31)22(30)24(35-26)11(2)28/h5-11,22-24,26,28-31H,1H2,2-4H3
    Key: XCWHINLKQMCRON-UHFFFAOYSA-N
  • O(C)C1=C2C(=C3C(C=4C(C(=O)O3)=CC(C=C)=CC4OC)=C1)C(=CC=C2O)[C@H]5O[C@@]([C@@H](C)O)([C@H](O)[C@H]5O)[H]
Properties
C27H26O9
Molar mass 494.496 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Gilvocarcin V is an antitumor agent and an antibiotic which is active against Gram-positive bacteria with the molecular formula C27H26O9. [3] [4] Gilvocarcin V is produced by the bacterium Streptomyces griseoflavus and other Streptomyces bacteria. [3] [4] [1] [5] [6] Gilvocarcin V is a strong inhibitor of the DNA synthesis. [6]

Related Research Articles

<span class="mw-page-title-main">Neomycin</span> Type of antibiotic

Neomycin is an aminoglycoside antibiotic that displays bactericidal activity against gram-negative aerobic bacilli and some anaerobic bacilli where resistance has not yet arisen. It is generally not effective against gram-positive bacilli and anaerobic gram-negative bacilli. Neomycin comes in oral and topical formulations, including creams, ointments, and eyedrops. Neomycin belongs to the aminoglycoside class of antibiotics that contain two or more amino sugars connected by glycosidic bonds.

<span class="mw-page-title-main">Oxytetracycline</span> Antibiotic

Oxytetracycline is a broad-spectrum tetracycline antibiotic, the second of the group to be discovered.

<i>Streptomyces</i> Genus of bacteria

Streptomyces is the largest genus of Actinomycetota, and the type genus of the family Streptomycetaceae. Over 700 species of Streptomyces bacteria have been described. As with the other Actinomycetota, streptomycetes are gram-positive, and have very large genomes with high GC content. Found predominantly in soil and decaying vegetation, most streptomycetes produce spores, and are noted for their distinct "earthy" odor that results from production of a volatile metabolite, geosmin. Different strains of the same species may colonize very diverse environments.

In organic chemistry, polyketides are a class of natural products derived from a precursor molecule consisting of a chain of alternating ketone and methylene groups: [−C(=O)−CH2−]n. First studied in the early 20th century, discovery, biosynthesis, and application of polyketides has evolved. It is a large and diverse group of secondary metabolites caused by its complex biosynthesis which resembles that of fatty acid synthesis. Because of this diversity, polyketides can have various medicinal, agricultural, and industrial applications. Many polyketides are medicinal or exhibit acute toxicity. Biotechnology has enabled discovery of more naturally-occurring polyketides and evolution of new polyketides with novel or improved bioactivity.

<span class="mw-page-title-main">Clavulanic acid</span> Molecule used to overcome antibiotic resistance in bacteria

Clavulanic acid is a β-lactam drug that functions as a mechanism-based β-lactamase inhibitor. While not effective by itself as an antibiotic, when combined with penicillin-group antibiotics, it can overcome antibiotic resistance in bacteria that secrete β-lactamase, which otherwise inactivates most penicillins.

Streptomyces spectabilis is a bacterium species from the genus of Streptomyces. Streptomyces spectabilis produces hangtaimycin, gentamicin, kanamycin, neomycin B, sisomycin, tobramycin, paromomycin, spectinabilin, spectinomycin, aminocyclitol, actinospectacin, prodigiosine and the streptovaricin complex.

<span class="mw-page-title-main">Nogalamycin</span> Chemical compound

Nogalamycin is an anthracycline antibiotic produced by the soil bacteria Streptomyces nogalater. It has antitumor properties but it is also highly cardiotoxic. The less cardiotoxic semisynthetic analog menogaril was developed in the 1970s. Currently nogalamycin and menogaril are not used clinically.

<i>Amycolatopsis orientalis</i> Species of bacterium

Amycolatopsis orientalis is a Gram-positive bacterium in the phylum Actinomycetota. It produces several substances with antimicrobial properties, including the antibiotic drug vancomycin.

Streptomyces arenae is a bacterium species from the genus Streptomyces which has been isolated from soil from Illinois in the United States. Streptomyces arenae produces pentalenolactone, 2,5-dihydrophenylalanine, naphthocyclinone and arenaemycine.

Streptomyces azureus is a bacterium species from the genus of Streptomyces which has isolated from soil. Streptomyces azureus produces the antibiotic thiostrepton.

Streptomyces cacaoi is a bacterium species from the genus of Streptomyces. Streptomyces cacaoi produces polyoxine.

Streptomyces griseoviridis is a filamentous bacterium species from the genus Streptomyces, which was isolated from soil in Texas, United States. Streptomyces griseoviridis produces etamycin, griseoviridin, bactobolin, prodigiosin R1, actinobolin, and rosophilin. Streptomyces griseoviridis can be used to protect plants since it inhibits the growth of fungal pathogens.

Streptomyces halstedii is a bacterium species from the genus of Streptomyces which has been isolated from deeper soil layers. Streptomyces halstedii produces magnamycin B, vicenistatin deltamycin A2, deltamycin A3, bafilomycin B1 and bafilomycin C1. Streptomyces halstedii also produces complex antifungal antibiotics like oligomycins and the antibiotics anisomycin and sinefungin.

Streptomyces kasugaensis is a bacterium species from the genus of Streptomyces which has been isolated from soil from the city Nara in Japan. Streptomyces kasugaensis produces kasugamycin and thiolutin.

<i>Streptomyces netropsis</i> Species of bacterium

Streptomyces netropsis is a bacterium species from the genus of Streptomyces. Streptomyces netropsis produces the antibiotics netropsin and distamycin A and the antifungal polyene mycoheptin.

Streptomyces nogalater is a bacterium species from the genus of Streptomyces. Streptomyces nogalater produces nogalamycin.

Streptomyces rishiriensis is a bacterium species from the genus of Streptomyces which has been isolated from soil in Hokkaido in Japan. Streptomyces rishiriensis produces coumermycin A1, notomycin, 2-chloroadenosine, phosphophenylalanarginine and lactonamycin.

Streptomyces sanglieri is a bacterium species from the genus of Streptomyces which has been isolated from soil from a hay meadow. Streptomyces sanglieri produces the antibiotic lactonamycin Z.

Streptomyces virginiae is a bacterium species from the genus of Streptomyces which has been isolated from soil. Streptomyces virginiae produces actithiazic acid, virginiamycins and cycloserine. Streptomyces virginiae also produces monensin A, monensin B, monensin C, monensin D, actithiazic acid.

<span class="mw-page-title-main">Tomaymycin</span> Chemical compound

Tomaymycin is an antitumor and antibiotic pyrrolobenzodiazepine with the molecular formula C16H20N2O4. Tomaymycin is produced by the bacterium Streptomyces achromogenes.

References

  1. 1 2 3 "Gilvocarcin V". Pubchem.ncbi.NLM.nih.gov.
  2. 1 2 3 "Gilvocarcin V (Anandimycin A, Toromycin B, Antibiotic 1072B), CAS [77879-90-4] | BIOZOL". www.biozol.de.
  3. 1 2 Comprehensive Natural Products II: Chemistry and Biology. Elsevier. 5 March 2010. p. 257. ISBN   978-0-08-045382-8.
  4. 1 2 Buckingham, John (1987). Dictionary of Organic Compounds. Taylor & Francis. p. 359. ISBN   978-0-412-17050-8.
  5. Fischer, Carsten; Lipata, Fredilyn; Rohr, Jürgen (1 July 2003). "The Complete Gene Cluster of the Antitumor Agent Gilvocarcin V and Its Implication for the Biosynthesis of the Gilvocarcins". Journal of the American Chemical Society. 125 (26): 7818–7819. doi:10.1021/ja034781q. PMC   4480634 . PMID   12822997.
  6. 1 2 Progress in Medicinal Chemistry. Elsevier. 1 January 1985. p. 20. ISBN   978-0-08-086270-5.

Further reading